The better survival in premenopausal females could probably be explained by higher levels of estradiol and progesterone.
Raleigh, NC (PRWEB) June 28, 2015
Scientists at the University of New South Wales have just released the results of a study comparing mesothelioma survival in men and women. The results suggest that certain hormones may offer some protection against this aggressive cancer.Click here to read the full story on Surviving Mesothelioma.
The study focused on 52 consecutive peritoneal mesothelioma patients treated at St. George Hospital in Sydney between 1996 and 2013. When patients were divided by age and gender, researchers found that premenopausal women had the best survival.
“The better survival in premenopausal females could probably be explained by higher levels of estradiol and progesterone,” writes study author Yeqian Huang.
The report, in the World Journal of Surgical Oncology, suggests that it may be worthwhile to study the potential therapeutic effects of sex steroid hormones for mesothelioma.
“By helping to explain why women mesothelioma patients tend to live longer than men, this study may open the door to a new approach to treating the disease, which tends to be highly resistant to conventional therapies,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.
Read all the details of the new research on the Surviving Mesothelioma website. See Sex Hormones May Account for Better Mesothelioma Survival in Women.
Huang, Y, et al, “Effects of sex hormones on survival of peritoneal mesothelioma”, June 26, 2015, World Journal of Surgical Oncology, Epub ahead of print, http://www.wjso.com/content/13/1/210/abstract
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.